Clinical Trial Update: Intranasal Dexmedetomidine for Procedural Pain Management in Elderly Adults in Palliative Care [Phase 3]

View source ↗

Summary

Phase 3 trial update for intranasal dexmedetomidine in elderly adults for analgesia and sedation in palliative care; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Analgesia
• Anxiolysis
• Sedation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Walid HABRE | Conditions: Analgesia, Sedation | Phase 3 | Status: TERMINATED